| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |